Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1996-09-12
1998-04-28
Kight, John
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 189, 544295, 544357, 544360, 514252, A61K 5104, C07D40100, C07D40300, C07D24102
Patent
active
057441219
ABSTRACT:
ethylpiperazine have affinity and specificity for serotonin 5-HT.sub.1A receptors.
REFERENCES:
patent: 5075303 (1991-12-01), Cliffe et al.
patent: 5135931 (1992-08-01), Carlier et al.
patent: 5166157 (1992-11-01), Lavielle et al.
patent: 5169845 (1992-12-01), Cliffe et al.
patent: 5177078 (1993-01-01), Ward et al.
patent: 5364849 (1994-11-01), Cliffe et al.
patent: 5369103 (1994-11-01), Cliffe
patent: 5382583 (1995-01-01), Cliffe
patent: 5420278 (1995-05-01), Cliffe
patent: 5532242 (1996-07-01), Cliffe
Hillver et al., "(S)-5-Fluoro-8-Hydroxy-2-(dipropylamino)tetralin: A 1541-1544 (1990).
Raghupathi et al., "Analogues of the 5-HT.sub.1A Serotonin Antagonist .alpha..sub.1 -Adrenergic Affinity", J. Med. Chem. 34:2633-2638 (1991).
Glennon et al., "Arylpiperazine Derivatives as High-Affinity 5-HT.sub.1A Serotonin Ligands", J. Med. Chem. 31: 1968-1971 (1988).
Hjorth et al., "8-Hydroxyl-2-(Di-N-Propylamino)Tetralin 8-OH-DPAT, A Potent and Selective Simplified Ergot Congener with Central 5-HT-Receptor Stimulating Activity", J. Neural Transmission 55: 169-188 (1982).
Zhuang et al., "Synthesis of (R,S)Trans-8-Hydroxy-2-(N-n-propyl-N-3'-iodo-2'-propenyl amino!tetraline (trans-8-OH-PIPAT): A New 5-HT.sub.1A Receptor Ligand", J. Med. Chem. 36: 3161-3165 (1993).
Greuel and Glaser, "The Putative 5-HT.sub.1A Receptor Antagonists NAN-190 and BMY 7378 are Partial Agonists in the Rat Dorsal Raphe Nucleus In Vitro", Eur, J. Pharmacol. 211: 211-219 (1992).
Fletcher et al., "WAY100135: A Novel, Selective Antagonist at Presynaptic and Postsynaptic 5-HT.sub.1A Receptors", Eur. J. Pharmacol. 237: 283-291 (1993).
Cliffe et al., "(S)-N-Tert-Butyl-3-(4-(2-methoxyphenyl)--piperazin-1-yl)-2-phenylpropanam ide, (S)-WAY-100135!: A Selective Antagonist at Presynaptic and Postsynaptic 5-HT.sub.1A Receptors", J. Med. Chem. 36: 1509-1510 (1993).
Fletcher, A., et al., "Silent 5-HT.sub.1A Receptor Antagonists: Utility As Research Tools and Therapeutic Agents," TIPS 4: 441-448 (1993).
Cliffe et al., The Design of Selective 5-HT.sub.1A Receptor Antagonists. 206th ACS Meeting, MEDI Abs. #30 (1990).
Chumpradit et al., "Iodinated Tomoxetine Derivatives as Selective Ligands for Serotonin and Norepinephrine Uptake Sites", J. Med. Chem. 35: 4492-4497 (1992).
Foreman et al., "Preclinical Studies on LY228729: A Potent and Selective Serotonin.sub.1A Agonist", J. Pharm and Exp. Ther 267: 58-71 (1993).
Wijingaarden et al., "2-Phenylpyrroles as Conformationally Restricted Benzamide Analogues. A New Class of Potential Antipsychotics." J.Med.Chem.30: 2099-2104 (1987) (See Figure 1 p. 2102).
Kelley Lara C.
Kight John
The Trustees of the University of Pennsylvania
LandOfFree
Serotonin (5-HT.sub.1A) receptor ligands and imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serotonin (5-HT.sub.1A) receptor ligands and imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serotonin (5-HT.sub.1A) receptor ligands and imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1529738